<p>China Resources Pharmaceutical (03320.HK) announced that its subsidiary CR Sanjiu (000999.SZ) achieved an operating income of 21.986 billion RMB in the first three quarters, an increase of 11.4% year-on-year. It recorded a net profit of 2.899 billion RMB, a decline of 10.6%</p>

000999

<p>China Resources Pharmaceutical announced that its subsidiary CR Sanjiu achieved an operating income of RMB 21.986 billion in the third quarter, an increase of 11.4% year-on-year. It recorded a net profit of RMB 2.899 billion, a decline of 10.6%</p>

China Resources Pharmaceutical's subsidiary CR Sanjiu earned 2.899 billion yuan in the first three quarters, a decline of 10.6%